Advertisement Acura Pharma names interim CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Acura Pharma names interim CEO

Acura Pharmaceuticals, a specialty pharmaceutical company engaged in research, development and manufacture of product candidates, has named Robert Jones as the company's interim president and CEO with immediate effect.

Jones has been working with Acura Pharma since April 2008 as the senior vice president and chief operating officer.

Jones succeeds Andy Reddick, who passed away on 28 April 2011.

Prior to Acura, Jones worked as the vice president of Strategic and Business Analysis of Adolor Corporation.